Lupin Seeks To Preempt Claim Over Ramipril Patent

Law360, New York (June 6, 2008, 12:00 AM EDT) -- Generics drugmaker Lupin Ltd. has asked a judge to find it doesn't infringe a patent licensed to rival King Pharmaceuticals Inc. for the hypertension drug Altace, several months after winning a dispute over another patent for the same drug.

Mumbai, India-based Lupin and its American marketing affiliate, Lupin Pharmaceuticals Inc., filed the suit for declaratory judgment Thursday in the U.S. District Court for the Eastern District of Virginia. The complaint names King and Germany's Sanofi-Aventis Deutschland GmbH, which owns the patent-in-suit.

Aventis licenses U.S. Patent Number...
To view the full article, register now.